Login / Signup

Generation of evidence-based carboplatin dosing guidelines for neonates and infants.

Shelby BarnettGuy MakinDeborah A TweddleCaroline OsborneGareth J Veal
Published in: British journal of cancer (2023)
Adoption of these evidence-based carboplatin doses in neonates and infants will reduce drug exposure variability and positively impact treatment.
Keyphrases
  • phase ii study
  • low birth weight
  • phase iii
  • clinical practice
  • preterm infants
  • squamous cell carcinoma
  • randomized controlled trial
  • clinical trial
  • open label
  • adverse drug
  • drug induced
  • smoking cessation